Literature DB >> 9270740

Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers.

F G Cobelens1, A Leentvaar-Kuijpers.   

Abstract

Self-reported compliance with a malaria chemoprophylaxis regimen of proguanil (PG) plus chloroquine (CQ) was assessed in a cohort of 547 Dutch travellers who visited a single travel clinic when travelling to various areas endemic for falciparum malaria. 503 (92%) had taken PG/CQ prophylaxis, but only 326 (60%) reported regular and uninterrupted use throughout the journey and 4 weeks afterwards. Compliance differed by travel destination and was 45% in South America, 52% in West Africa, 53% in South-east Asia, 60% in the Indian Subcontinent and 78% in East Africa. Parasitologically confirmed falciparum malaria occurred in 5 travellers (0.9%), including 3 of 24 non-compliant travellers to West Africa (12.5%). Apart from destination, independent risk factors for non-compliance were young age, extensive travel experience and adventurous travel. Compliance with protection against mosquito bites was 80% for wearing long-sleeved shirts and long-legged trousers after sunset, 73% for use of repellents, 56% for sleeping under bed nets and 37% for keeping the sleeping quarters free of mosquitoes. Although 440 travellers (80%) reported to have taken two or more of these measures at least once, only 88 (16%) had done so on a daily basis. Daily use of bed nets was reported more frequently among subjects who were non-compliant with chemoprophylaxis. Compliance regarding malaria chemoprophylaxis should be improved, particularly in high-risk areas such as Sub-saharan Africa, with extra attention to young, adventurous travellers. More emphasis should be placed on prevention of Anopheles bites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270740     DOI: 10.1046/j.1365-3156.1997.d01-357.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  11 in total

1.  Autonomic function in patients with chronic fatigue syndrome.

Authors:  P M Soetekouw; J W Lenders; G Bleijenberg; T Thien; J W van der Meer
Journal:  Clin Auton Res       Date:  1999-12       Impact factor: 4.435

2.  Success of malaria chemoprophylaxis for outbound civil and military travellers in prevention of reintroduction of malaria in Sri Lanka.

Authors:  Sumadhya D Fernando; Dewanee Ranaweera; Methnie S Weerasena; Rahuman Booso; Thamara Wickramasekara; Chirath P Madurapperuma; Manjula Danansuriya; Chaturaka Rodrigo; Hemantha Herath
Journal:  Int Health       Date:  2020-07-01       Impact factor: 2.473

3.  Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa.

Authors:  Noémie Resseguier; Vanessa Machault; Lénaick Ollivier; Eve Orlandi-Pradines; Gaetan Texier; Bruno Pradines; Jean Gaudart; Alain Buguet; Catherine Tourette-Turgis; Christophe Rogier
Journal:  Malar J       Date:  2010-02-03       Impact factor: 2.979

4.  Usefulness of quantitative nucleic Acid sequence-based amplification for diagnosis of malaria in an academic hospital setting.

Authors:  H D F H Schallig; G J Schoone; E J M Lommerse; C C M Kroon; P J de Vries; T van Gool
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

5.  Determinants of compliance with anti-vectorial protective measures among non-immune travellers during missions to tropical Africa.

Authors:  Emmanuel Sagui; Noémie Resseguier; Vanessa Machault; Lénaïck Ollivier; Eve Orlandi-Pradines; Gaetan Texier; Frédéric Pages; Remy Michel; Bruno Pradines; Sébastien Briolant; Alain Buguet; Catherine Tourette-Turgis; Christophe Rogier
Journal:  Malar J       Date:  2011-08-10       Impact factor: 2.979

6.  Target product profiles for protecting against outdoor malaria transmission.

Authors:  Gerry F Killeen; Sarah J Moore
Journal:  Malar J       Date:  2012-01-11       Impact factor: 2.979

7.  Determinants of Adherence with Malaria Chemoprophylactic Drugs Used in a Traveler's Health Clinic.

Authors:  Ibrahim Shady
Journal:  J Trop Med       Date:  2015-08-24

8.  Severity of imported malaria: protective effect of taking malaria chemoprophylaxis.

Authors:  Klaske Vliegenthart-Jongbloed; Mariana de Mendonça Melo; Marlies E van Wolfswinkel; Rob Koelewijn; Jaap J van Hellemond; Perry J J van Genderen
Journal:  Malar J       Date:  2013-07-31       Impact factor: 2.979

9.  Use of short message service (SMS) to improve malaria chemoprophylaxis compliance after returning from a malaria endemic area.

Authors:  Lénaïck Ollivier; Olivier Romand; Catherine Marimoutou; Rémy Michel; Corinne Pognant; Alain Todesco; René Migliani; Dominique Baudon; Jean-Paul Boutin
Journal:  Malar J       Date:  2009-10-23       Impact factor: 2.979

10.  Adherence to chemoprophylaxis and Plasmodium falciparum anti-circumsporozoite seroconversion in a prospective cohort study of Dutch short-term travelers.

Authors:  Sanne-Meike Belderok; Anneke van den Hoek; Will Roeffen; Robert Sauerwein; Gerard J B Sonder
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.